NCPDP Invites Specialty Pharmacy Stakeholders to Participate in Work Group Meeting, August 3rd in St. Louis

Thursday, June 21, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

All industry stakeholders involved in specialty pharmacy are encouraged to register to participate in the work group meeting.

NEW YORK, June 21, 2018 /PRNewswire-PRWeb/ -- Driven by industry need and demand, NCPDP announced it has established

a specialty pharmacy work group to ease the administrative challenges of managing specialty medications for patients with chronic or complex medical conditions, and help speed time to therapy. At the work group's first meeting, which will be held August 3, 2018, in St. Louis, Missouri, participants will establish the scope and goals that will guide its work. All industry stakeholders involved in specialty pharmacy are encouraged to register to participate in the work group meeting.

NCPDP established the specialty pharmacy work group based on strong industry interest and demand, which reached critical mass over the past several months. Industry stakeholders expressed urgent need to standardize and automate manual processes that delay patients from getting specialty medications to improve processing, provide important clinical and administrative efficiencies, and importantly, improve the patient experience. They also validated that NCPDP is the right place, and has the right process and people to support efforts to improve specialty pharmacy.

Industry stakeholders involved in managing specialty medications have identified a number of processes – from enrollment and benefit verification, to prior authorizations, patient consent, and outcomes reporting – that can benefit from standardization to improve care coordination and streamline administrative functions.

"We are compelled to take action now to improve care quality and speed time to therapy," explained Lee Ann Stember, President and CEO of NCPDP. "It is gratifying to see so many people ready to devote their time and expertise to this new work group, and address the challenges faced by patients, physicians, pharmacists and others."

NCPDP's WG18 Specialty Pharmacy Co-Chairs are: Pooja Babbrah, MBA, PBM Practice Lead, Point-of-Care Partners, LLC; Julie Hessick, R.Ph., Director, Clinical and Regulatory Affairs, CoverMyMeds, LLC; and Laura Topor, President, Granada Health, Inc.

The first meeting of Work Group 18 Specialty Pharmacy, will be held on August 3, 2018, in St. Louis, Missouri, during NCPDP's Quarterly Joint Technical Work Group Meetings. For registration and hotel information, visit: http://ncpdp.org/Events/work-group-registration-information.aspx?ID=WGAug18.

About NCPDP Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with more than 1,500 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP's RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

SOURCE National Council For Prescription Drug Programs, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store